SAS Innovate: Turning Messy Data Into Meaningful Decisions With AI In Healthcare
Can faster access to real-world data actually change patient outcomes, or are we still too reliant on controlled clinical trials to see the full picture? In this episode, I sit down with Dr. Alex Asiimwe, Executive Director of Epidemiology at Gilead Sciences, to explore a topic that doesn't get enough attention in the AI conversation, real-world evidence. While much of the industry focuses on AI in drug discovery or diagnostics, Alex brings a different perspective, one rooted in what happens after treatments reach real patients in the real world. As he explains, clinical trials may be the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.